Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAIC 2017 | Mapping cognitive training in dementia

Etienne de Villers-Sidani • 17 Jul 2017
AAIC 2017
Dementia

Etienne de Villers-Sidani, MD from the Montreal Neurological Institute, Montreal, Canada discusses the experimental models used in his lab to study brain changes and cognitive training. Dr de Villers-Sidani describes how they study the auditory cortex of both mice and humans, using simple and complex training techniques. Imaging is then used to analyze changes in the brain in response to this training. This interview was recorded at the Alzheimer’s Association International Conference (AAIC) 2017, London, UK.

More from Etienne de Villers-Sidani

Cognitive training: a complex field
1:24
Cognitive training: a complex field
Etienne de Villers-Sidani • 4 Sep 2017
Training to compensate for cognitive decline
1:46
Training to compensate for cognitive decline
Etienne de Villers-Sidani • 4 Sep 2017
The complicated relationship between technology and cognitive training
1:54
The complicated relationship between technology and cognitive training
Etienne de Villers-Sidani • 4 Sep 2017
Stimulating strategies to study cognition
1:37
Stimulating strategies to study cognition
Etienne de Villers-Sidani • 17 Jul 2017

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
The Lewy Body Society's mission and impact
2:38
The Lewy Body Society's mission and impact
Jacqui Cannon • 5 Aug 2026
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
2:44
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
Jacqui Cannon • 5 Aug 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals